top of page
Lundbeck Japan K.K.

Lundbeck Japan K.K.


Kamiyacho Prime Place, 4-1-17 Toranomon, Minato-ku, Tokyo 105-0001, Japan

Tel 03-5733-8690
Fax 03-5733-8691

Lundbeck Japan K.K. is a subsidiary of H. Lundbeck A/S headquartered in Copenhagen, Denmark. H. Lundbeck A/S was founded in 1915 and is the only fully integrated pharmaceutical company focusing entirely on improving quality of life for people living with brain diseases.

Lundbeck Japan K.K. was inaugurated in 2001. In 2011, our partner, Mochida Pharmaceutical Co. Ltd., obtained marketing authorisation for escitalopram (Lexapro®; エスシタロプラム) as the first product invented by Lundbeck introduced to the Japanese market. We are proud that Lexapro® which has been made available to more than 300 mill. patients worldwide, now is available also for Japanese living with depression.

In addition to our strong local collaboration with Mochida Pharmaceutical Co., Ltd. in Japan, on a global scale Lundbeck has entered into excellent partnerships with major Japanese pharmaceutical companies such as Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co., Ltd. and Kyowa Hakko Kirin Co., Ltd. Currently we are experiencing a growing business in Japan and we expect to grow it further in the future.

To develop drugs for brain diseases, that is psychiatry and neurology, is probably one the most complex and challenging areas to operate in. Therefore, as a company, we aim to attract the sharpest minds in Japan to join forces with us in developing and commercializing the ‘treatments of tomorrow’.

Lundbeck is a global company and it is therefore essential with a global mindset. Additionally, we believe that a creative and productive mind is nurtured through a healthy work-life balance which allows for spending time with friends and family. This is in our experience, not only achievable, but also a supporting factor for enabling us to reach our ambitious objectives of making a difference for Japanese people living with brain diseases.

Please visit our website for more information about Lundbeck.

ルンドベック・ジャパン株式会社は、デンマークのコペンハーゲンにあるH.ルンドベック社の子会社です。H.Lundbeck A/S社は1915年に設立され、脳疾患におけるQOL改善に特化した唯一の完全統合型製薬企業です。




H. ルンドベック社はグローバル企業であるため、国際的な発想が大変重要となります。また、弊社では、創造的で生産性の高い精神は、家族や友人と十分な時間を過すことのできる健全なワーク・ライフ・バランスによって生み出されると考えています。私たちの経験から、健全なワーク・ライフ・バランスの確立は実現可能であるとともに、脳領域疾患に罹患する日本の患者さんへの貢献を目指す我々の意欲的な企業目標の推進にもつながると考えています。

bottom of page